![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients AMRI Signs API Development and Manufacturing Deal with Australian Firm3:45 AM MDT | April 8, 2011 | Deepti Ramesh Albany Molecular Research Inc. (AMRI; Albany, NY) says it has entered into a development and long term exclusive commercial supply agreement with Parnell Manufacturing (Alexandria, Australia), a company that specializes in the research, development and manufacture of veterinary products. AMRI will provide process development, manufacturing and supply of active pharmaceutical ingredients (APIs) to support Parnell's submission of a new animal drug application (NADA) with the U.S. Food and Drug Administration and commercial launch of its veterinary product onto the... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|